Imunon, Inc. — Director's Dealing 2012

Sep 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-20

Reporting Person: LINK MAX (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-20	Celsion Corporation Common Stock	M	17083	$3.25	Acquired	313108	Direct
2012-09-20	Celsion Corporation Common Stock	M	34542	$2.77	Acquired	347650	Direct
2012-09-20	Celsion Corporation Common Stock	M	18735	$4.22	Acquired	366385	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-20	Warrants to purchase Celsion Corporation Common Stock	$3.25	X	17083	Disposed	2016-06-20	Celsion Corporation Common Stock (17083)	Direct
2012-09-20	Warrants to purchase Celsion Corporation Common Stock	$2.77	X	34542	Disposed	2017-05-26	Celsion Corporation Common Stock (34542)	Direct
2012-09-20	Warrants to purchase Celsion Corporation Common Stock	$4.22	X	18735	Disposed	2016-07-25	Celsion Corporation Common Stock (18735)	Direct

Footnotes

F1: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the January 2011 8% Convertible Preferred Stock Offering. These warrants were fully exercisable with an exercise price of $3.25 per share. The Director has no immediate intent to sell these newly acquired shares.

F2: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the May 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.77 per share. The Director has no immediate intent to sell these newly acquired shares.

F3: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the July 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $4.22 per share. The Director has no immediate intent to sell these newly acquired shares.